{
    "2019-01-09": [
        [
            {
                "time": "2019-01-05",
                "original_text": "揭秘A股董事长年薪：平均91万 最高相差超7700倍",
                "features": {
                    "keywords": [
                        "A股",
                        "董事长",
                        "年薪",
                        "差距"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-01-06",
                "original_text": "威高股份逆市挫逾1% 遭大华继显降至卖出评级",
                "features": {
                    "keywords": [
                        "威高股份",
                        "逆市",
                        "下跌",
                        "评级下调"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗设备"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-01-07",
                "original_text": "医药生物行业2019年投资策略:创新才是硬道理",
                "features": {
                    "keywords": [
                        "医药生物",
                        "投资策略",
                        "创新"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-01-08",
                "original_text": "医药周报2019第2期:并购大事记 危与机并存",
                "features": {
                    "keywords": [
                        "医药",
                        "并购",
                        "机会",
                        "风险"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}